发明名称 HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES
摘要 HIV replication inhibitors of formula (I), N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a<SUP>1</SUP>=a<SUP>2</SUP>-a<SUP>3</SUP>=a<SUP>4</SUP>- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -N=N-CH=CH-; -b<SUP>1</SUP>=b<SUP>2</SUP>-b<SUP>3</SUP>=b<SUP>4</SUP>- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -N=N-CH=CH-; R<SUP>1</SUP> is hydrogen; aryl; formyl; C<SUB>1-6</SUB>alkylcarbonyl; optionally substituted C<SUB>1-6</SUB>alkyl; C<SUB>1-6</SUB>alkyloxycarbonyl; R<SUP>2</SUP> is OH; halo; optionally substituted C<SUB>1-6</SUB>alkyl, C<SUB>2-6</SUB>alkenyl or C<SUB>2-6</SUB>alkynyl; substituted carbonyl; carboxyl; CN; nitro; amino; substituted amino; polyhalomethyl; polyhalomethylthio; -S(=O)<SUB>P</SUB>R<SUP>6</SUP>; C(=NH)R<SUP>6</SUP>; R<SUP>2a</SUP> is CN; amino; substituted amino; optionally substituted C1-6alkyl; halo; optionally substituted C<SUB>1-6</SUB>alkyloxy; substituted carbonyl; -CH=N-NH-C(O)-R<SUP>16</SUP>; optionally substituted C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyl; substituted C<SUB>2-6</SUB>alkenyl or C<SUB> 2-6</SUB> alkynyl; -C(=N-O-R<SUP>8</SUP>)-C<SUB>1-4</SUB>alkyl; R<SUP>7</SUP> or -X<SUB>3</SUB>-R<SUP>7</SUP>; X<SUB>1</SUB> is -NR<SUP>1</SUP>-, -O-, -C(=O)-, -CH<SUB>2</SUB>-, -CHOH-, -S-, -S(=O)<SUB>P</SUB>- R<SUP>3</SUP> is CN; amino; C<SUB>1-6</SUB>alkyl; halo; optionally substituted C<SUB>1-6</SUB>alkyloxy; substituted carbonyl; -CH=N-NH-C(O)-R<SUP>16</SUP>; substituted C<SUB>1-6</SUB>alkyl; optionally substituted C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyl; substituted C<SUB>2-6</SUB>alkenyl or C<SUB>2-6</SUB>alkynyl; -C(=N-O-R<SUP>8</SUP>)-C<SUB>1-4</SUB>alkyl; R<SUP>7</SUP>; -X<SUB>3</SUB>-R<SUP>7</SUP> ; R<SUP>4</SUP> is halo; OH; optionally substituted C<SUB>1-6</SUB>alkyl, C<SUB>2-6</SUB>alkenyl or C<SUB>2-6</SUB>alkynyl; C<SUB>3-7</SUB>cycloalkyl; C<SUB>1-6</SUB>alkyloxy; CN; nitro; polyhaloC<SUB>1-6</SUB>alkyl; polyhaloC<SUB>1-6</SUB>alkyloxy; substituted carbonyl; formyl; amino; mono- or di(C<SUB>1-4</SUB>alkyl)amino or R<SUP>7</SUP>; R<SUP>5</SUP> is a 5- or 6-membered completely unsaturated ring system wherein 1 - 4 ring members are nitrogen, oxygen or sulfur; which ring may optionally be substituted and may optionally be annelated with a benzene ring; methods for their preparation and pharmaceutical compositions comprising them. The invention also relates to the use of these compounds for the prevention or the treatment of HIV infection.
申请公布号 WO2006035067(A3) 申请公布日期 2006.08.24
申请号 WO2005EP54930 申请日期 2005.09.29
申请人 TIBOTEC PHARMACEUTICALS LTD.;GUILLEMONT, JEROME, EMILE, GEORGES;HEERES, JAN;LEWI, PAULUS, JOANNES 发明人 GUILLEMONT, JEROME, EMILE, GEORGES;HEERES, JAN;LEWI, PAULUS, JOANNES
分类号 C07D401/04;A61K31/505;A61P31/18;C07D405/04;C07D409/04;C07D413/04;C07D413/14;C07D417/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址